Home
Chiome Bioscience

Chiome Bioscience Market Share Analysis for July 2026

医療のアンメットニーズに創薬の光を

Health > Biotechnology and Pharmaceuticals

Domainchiome.co.jp

Year Founded2005

Employees51 - 200

Annual Revenue$5M - $10M

Chiome Bioscience

Chiome Bioscience (including company regionals)

chiome.co.jp

See more website traffic and engagement information

Chiome Bioscience Revenue up to July 2026 is 5M - 10M

revenue generated by Chiome Bioscience top domains

Chiome Bioscience top domains revenue over 3 years

Revenue for Chiome Bioscience top domains

chiome.co.jp5M - 10M

See more with Sales Intelligence

Total visits to Chiome Bioscience's top domains

Understand Chiome Bioscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

chiome.co.jp2.2K

See more with Sales Intelligence

Avg. visit duration in Chiome Bioscience's top domains

Analyze Chiome Bioscience engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

chiome.co.jp00:02:14

See more with Sales Intelligence

Avg. pageviews on Chiome Bioscience's top domains

See how Chiome Bioscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

chiome.co.jp3.49

See more with Sales Intelligence

Chiome Bioscience top competitors by domain

Top similar sites in July 2026, ranked by their affinity

fujipharma.jpCompany NameFuji Pharma Co., Ltd.Employees1001 - 5000HQJapan, SanbanchouAnnual revenue$200M - $500MTotal visits35.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Chiome Bioscience

These are the website technologies, by industry, used by Chiome Bioscience top domains

Advertising (4)

Google Adsense

Audio Video Media (2)

YouTube

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

6

See all

News & Signals from Chiome Bioscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlfresa Holdings Corporation partnered with Chiome Bioscience on Oct 6th '25.On 6 October 2025, Alfresa Holdings announced that it has entered into agreements with two other Japanese companies, Kidswell Bio Corporation and Chiome Bioscience... Read more here.

NewsVelabs Therapeutics GmbH partners with Chiome Bioscience.Germany-based Velabs, a company specializing in the fast generation of functional therapeutic antibodies, struck a deal with Chiome Bioscience, Inc., Tokyo to jointly discover modulatory and functional antibodies for one of Chiome’s GPCR target genes.

NewsProBioGen AG signs new client Chiome Bioscience.Chiome Bioscience has selected ProBioGen to develop and manufacture its monoclonal antibody LIV-1205, which is designed to combat liver cancer and solid tumours.